Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOFLOXACIN Cause Upper respiratory tract infection? 216 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 216 reports of Upper respiratory tract infection have been filed in association with LEVOFLOXACIN (Levofloxacin). This represents 0.5% of all adverse event reports for LEVOFLOXACIN.

216
Reports of Upper respiratory tract infection with LEVOFLOXACIN
0.5%
of all LEVOFLOXACIN reports
15
Deaths
64
Hospitalizations

How Dangerous Is Upper respiratory tract infection From LEVOFLOXACIN?

Of the 216 reports, 15 (6.9%) resulted in death, 64 (29.6%) required hospitalization, and 3 (1.4%) were considered life-threatening.

Is Upper respiratory tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOFLOXACIN. However, 216 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOFLOXACIN Cause?

Drug hypersensitivity (3,660) Neuropathy peripheral (2,619) Arthralgia (2,594) Pain in extremity (2,317) Pain (2,266) Drug ineffective (2,181) Dyspnoea (2,074) Tendonitis (1,813) Aortic aneurysm (1,767) Nausea (1,694)

What Other Drugs Cause Upper respiratory tract infection?

ADALIMUMAB (3,306) ETANERCEPT (2,948) TOFACITINIB (1,805) RITUXIMAB (1,713) ABATACEPT (1,623) METHOTREXATE (1,576) TOCILIZUMAB (1,455) APREMILAST (1,437) PREDNISONE (1,354) SECUKINUMAB (1,339)

Which LEVOFLOXACIN Alternatives Have Lower Upper respiratory tract infection Risk?

LEVOFLOXACIN vs LEVOKETOCONAZOLE LEVOFLOXACIN vs LEVOLEUCOVORIN LEVOFLOXACIN vs LEVOMEPROMAZINE LEVOFLOXACIN vs LEVOMETHADONE LEVOFLOXACIN vs LEVOMILNACIPRAN

Related Pages

LEVOFLOXACIN Full Profile All Upper respiratory tract infection Reports All Drugs Causing Upper respiratory tract infection LEVOFLOXACIN Demographics